Skip to main content
logo
Helus Pharma Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
10.74
+0.19 (1.80%)
Oct 19, 2026, 3:34 PM EDT - Market open

Helus Pharma Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-167.05-142.59-103.13-58.22-38.08-51.13
Net Income
-171.2-148-81.61-57.66-35.1-54.17
Earnings Per Share
-4.05-4.25-4.04-6.95-7.30-12.30
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
166.37157.2693.92154.3412.2942.97
Total Debt
---0.21--
Net Cash (Debt)
166.37157.2693.92154.1212.2942.97
Net Cash Growth
124.24%67.44%-39.06%1153.71%-71.39%-15.59%
Net Cash Per Share
3.934.524.6418.572.529.76

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-140.79-133.27-72.33-50.89-35.06-36.21
Capital Expenditures
0.03-0.19-0.03-0.02-0.1-0.08
Free Cash Flow
-140.76-133.46-72.35-50.9-35.16-36.29
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
------